R
Rachael Hunter
Researcher at University College London
Publications - 169
Citations - 3722
Rachael Hunter is an academic researcher from University College London. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 26, co-authored 139 publications receiving 2462 citations. Previous affiliations of Rachael Hunter include University of Manchester.
Papers
More filters
Journal ArticleDOI
Crisis resolution teams for people experiencing mental health crises: the CORE mixed-methods research programme including two RCTs
Brynmor Lloyd-Evans,Marina Christoforou,David Osborn,David Osborn,Gareth Ambler,Louise Marston,Danielle Lamb,Oliver Mason,Nicola Morant,Sarah A Sullivan,Claire Henderson,Rachael Hunter,Stephen Pilling,Fiona Nolan,Richard Gray,Tim Weaver,Kathleen Kelly,Nicky Goater,Alyssa Milton,Elaine Johnston,Kate Fullarton,Melanie Lean,Beth Paterson,Jonathan Piotrowski,Michael Davidson,Rebecca Forsyth,Liberty Mosse,Monica Leverton,Puffin O’Hanlon,Edward Mundy,Tom Mundy,Ellie Brown,Sarah Fahmy,Emma Burgess,Alasdair Churchard,Claire Wheeler,Hannah Istead,David Hindle,Sonia Johnson,Sonia Johnson +39 more
TL;DR: The peer-provided self-management intervention is an effective means to reduce relapse rates for people leaving CRT care and showed potential promise as a means to increase CRT model fidelity and reduce inpatient service use.
Journal ArticleDOI
Planned delivery or expectant management for late preterm pre-eclampsia: study protocol for a randomised controlled trial (PHOENIX trial).
Lucy C Chappell,Marcus Green,Neil Marlow,Jane Sandall,Rachael Hunter,Stephen C. Robson,Ursula Bowler,Virginia Chiocchia,Pollyanna Hardy,Edmund Juszczak,Louise Linsell,Anna Placzek,Peter Brocklehurst,Andrew Shennan +13 more
TL;DR: The PHOENIX trial aims to address the uncertainty for women where the balance of benefits and risks of delivery compared to expectant management are uncertain and to influence clinical practice internationally, through direct adoption and by incorporation into guidelines in countries with similar settings.
Journal ArticleDOI
LiGHT trial: 6-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension.
Gus Gazzard,Evgenia Konstantakopoulou,David F. Garway-Heath,Mariam Adeleke,Victoria Vickerstaff,Gareth Ambler,Rachael Hunter,Catey Bunce,Neil Nathwani,Keith Barton +9 more
TL;DR: The LiGHT trial as mentioned in this paper showed that the use of trabeculoplastic surgery was clinically and cost-effective as a primary treatment of open-angle glaucoma and ocular hypertension at 3 years.
Journal ArticleDOI
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial
Jonathan G. Best,Liz Arram,Norin Ahmed,Maryam Balogun,Kate Bennett,Ekaterina Bordea,M. Garcia Campos,Emilia Caverly,Marisa Chau,Hannah Cohen,Hakim-Moulay Dehbi,Caroline J Doré,Stefan T. Engelter,Robert Fenner,Nick Freemantle,Rachael Hunter,Martin A. James,Gregory Y.H. Lip,Macey L. Murray,Bo Norrving,Nikola Sprigg,Roland Veltkamp,Iwona Zaczyk,David J. Werring +23 more
TL;DR: Whether early treatment with a direct oral anticoagulant, within four days of stroke onset, is as effective or better than delayed initiation, 7 to 14 days from onset, in atrial fibrillation patients with acute ischemic stroke is investigated.
Journal ArticleDOI
A modelling-based economic evaluation of primary-care-based fall-risk screening followed by fall-prevention intervention: a cohort-based Markov model stratified by older age groups
Matthew Franklin,Rachael Hunter +1 more
TL;DR: Although the model does not fully represent current NICE Falls guidance, decision makers should still give careful consideration to implementing the aforementioned care pathway due to the modelled high probability of cost-effectiveness.